e-learning
resources
Milan 2017
Sunday, 10.09.2017
Late-breaking findings in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Adherence to GOLD recommendations in Italian patients with COPD categorised as frequent and non-frequent exacerbators: The MISTRAL study
R. Pela (Ancona, AN, Italy)
Source:
International Congress 2017 – Late-breaking findings in asthma and COPD
Session:
Late-breaking findings in asthma and COPD
Session type:
Thematic Poster
Number:
1358
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Pela (Ancona, AN, Italy). Late Breaking Abstract - Adherence to GOLD recommendations in Italian patients with COPD categorised as frequent and non-frequent exacerbators: The MISTRAL study. 1358
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
Late Breaking Abstract - HRQol and other health related variables of Spanish COPD patients
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Late Breaking Abstract - Long-term variability of blood eosinophils in COPD patients by GOLD 2017 staging, and gender bias
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
The hospital debut of COPD patients. The "Phenotype and Course of COPD" (PAC-COPD) Study
Source: Eur Respir J 2005; 26: Suppl. 49, 218s
Year: 2005
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
The German COPD cohort COSYCONET: Aims, methods and results of recruitment
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Late Breaking Abstract - Cardiovascular risk and COPD in a population-based study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021
An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR)
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019
Late Breaking Abstract - Response to mepolizumab in patients with severe CRSwNP using EUFOREA 2021 criteria
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Late Breaking Abstract - Optimizing FEV1/FVC threshold to predict COPD hospitalization and mortality: NHLBI pooled cohorts study
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018
Late Breaking Abstract - Ten-year risk score for COPD: the NHLBI pooled cohorts study
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Late Breaking Abstract - Use of a simple telecoaching pulmonary rehabilitation protocol for COPD patients.
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
Assessment of patients with COPD according to previous and new GOLD: Which stage in which group?
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
Stability of the frequent exacerbator – A Danish nationwide register-based study
Source: International Congress 2016 – Management of asthma and COPD in primary care
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept